Glenmark Generics (GGL), a US subsidiary of Mumbai-India based Glenmark Phamaceuticals, has received approval for its generic version of hypertension drug verapamil extended release tablets from US FDA.
Sanofi-Aventis said that the US FDA has requested additional information regarding benefit-risk regarding the company’s New Drug Application (NDA) for insomnia treatment eplivanserin (Ciltyri).
Dr Reddy may sell five percent of the company's founders' stake holding to GlaxoSmithKline for a consideration of nearly $150 million, according to sources.
Indian generic firm Orchid Chemicals & Pharmaceuticals has received approval from US FDA for its generic version of zaleplon pills used in the treatment of insomnia or sleeplessness.
MSD Wellcome Trust Hilleman Laboratories is expected to start by the end of next year in India